National Cancer Institute

Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG). Read More

Vanderbilt’s Ian Macara, Ph.D., has won an Outstanding Investigator Award from the National Cancer Institute (NCI) — nearly $6.6 million over seven years — to support the “unusual potential” of his research, which seeks to understand and predict cancer cell “behavior.” Read More

The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011. Read More

Louis Staudt, M.D., Ph.D., director of the National Cancer Institute (NCI) Center for Cancer Genomics and co-chief of the NCI’s Lymphoid Malignancies Branch, spoke about new lymphoma therapies at his recent Flexner Discovery Lecture. Read More

Louis Staudt, M.D., Ph.D., a pioneer in gene expression profiling at the National Cancer Institute (NCI), will deliver the next Flexner Discovery Lecture on Thursday, March 19. Read More

The director of the National Cancer Institute, Harold Varmus, M.D., will deliver the next Flexner Discovery Lecture on Thursday, Nov. 21. His lecture, “New Directions in Cancer Research,” will begin at 4 p.m. in 208 Light Hall. Read More

Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute. Read More

Green tea may lower risk of some digestive cancers. Read More

Low folate levels may increase a premenopausal woman’s risk of developing breast cancer. Read More

A new lung cancer study led by Vanderbilt-Ingram Cancer Center investigators found that various non-small cell lung cancer cells grow at different rates, which may explain why some tumors become resistant to anti-cancer drugs faster than others. Read More

Loss of the protein p120 in the intestinal lining sets the stage for tumor formation. Read More

Helicobacter pylori, a bacterium that infects half of the world’s population and increases the risk for stomach cancer, appears to impair nutrient absorption. Read More

Vanderbilt-Ingram Cancer Center researchers have identified six subtypes of an aggressive and difficult-to-treat form of breast cancer. Read More

Antioxidant genes may be good targets for treating a stomach disorder that affects up to 40 percent of patients with diabetes. Read More

(stock.xchng) After years of confusion about the safety of soy food consumption by breast cancer survivors, a large new study found that eating soy foods did not increase the risk of cancer recurrence or death among breast cancer survivors. The study was presented at the American Association for Cancer… Read More

People who smoke mentholated cigarettes are no more likely to develop lung cancer or die from the disease than are smokers of non-mentholated brands, a new study shows. Read More

New research about the link between body weight and mortality among Asians, which has not been studied in the past, finds being severely underweight poses a serious threat for this population and that preventing obesity is the top priority moving forward. Read More